Skip to Main Content


EISSN 2059-6553
  • Cover Image

    Cover Image

    issue cover
    In the latest issue of Neuronal Signaling (volume 3, issue 2), White et al. test the therapeutic efficacy of modulating collapsin response mediator protein 2 (CRMP2) activity via S-N-benzy-2-acetamido-3-methoxypropionamide ((S)-Lacosamide) on CLN6-Batten disease - a rare neurodegenerative disorder with no current cure. This cover features a representative image from their study, depicting classic Batten disease pathology in Cln6 mutant mouse brains.
Close Modal
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close Modal
Close Modal